Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek Skinner

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Drugs|November 22, 2019
Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting β<sub>2</sub>-Agonist Fluticasone Propionate/Formoterol Fumarate: A 36-Month Longitudinal Cohort Study in UK Primary CareDavid B Price, Victoria Carter, Jessica Martin, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 29, 2023
A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPDGary Tse, Benjamin Emmanuel, Cono Ariti, et al.
Pragmatic and Observational Research|March 27, 2026
The Potential Impact of GLP-1 Receptor Agonists on Exacerbation Risk in Patients with COPD and Type 2 Diabetes: A Real-World Population-Based Observational StudyBernardino Alcázar-Navarrete, Heath Heatley, Alan Kaplan, et al.
Journal of Asthma and Allergy|May 24, 2017
Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchasesPete Smith, David Price, Richard Harvey, et al.
Pragmatic and Observational Research|August 28, 2018
Real-life treatment of rhinitis in Australia: a historical cohort study of prescription and over-the-counter therapies for patients with and without additional respiratory diseaseDavid B Price, Pete K Smith, Richard John Harvey, et al.
NPJ Primary Care Respiratory Medicine|March 4, 2023
Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthmaJohn Haughney, Trung N Tran, Heath Heatley, et al.
Plos One|September 23, 2016
Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort StudyDavid B Price, Richard Russell, Rafael Mares, et al.
Respiratory Medicine|July 23, 2017
Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluationSimon Wan Yau Ming, John Haughney, Iain Small, et al.
Thorax|December 27, 2022
Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthmaHeath Heatley, Trung N Tran, Arnaud Bourdin, et al.
The Journal of Allergy and Clinical Immunology. Global|March 25, 2024
Longitudinal patterns of intermittent oral corticosteroid therapy for asthma in the United KingdomTrung N Tran, Heath Heatley, Jennifer Rowell, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Drugs|November 22, 2019
Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting β<sub>2</sub>-Agonist Fluticasone Propionate/Formoterol Fumarate: A 36-Month Longitudinal Cohort Study in UK Primary CareDavid B Price, Victoria Carter, Jessica Martin, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 29, 2023
A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPDGary Tse, Benjamin Emmanuel, Cono Ariti, et al.
Pragmatic and Observational Research|March 27, 2026
The Potential Impact of GLP-1 Receptor Agonists on Exacerbation Risk in Patients with COPD and Type 2 Diabetes: A Real-World Population-Based Observational StudyBernardino Alcázar-Navarrete, Heath Heatley, Alan Kaplan, et al.
Journal of Asthma and Allergy|May 24, 2017
Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchasesPete Smith, David Price, Richard Harvey, et al.
Pragmatic and Observational Research|August 28, 2018
Real-life treatment of rhinitis in Australia: a historical cohort study of prescription and over-the-counter therapies for patients with and without additional respiratory diseaseDavid B Price, Pete K Smith, Richard John Harvey, et al.
NPJ Primary Care Respiratory Medicine|March 4, 2023
Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthmaJohn Haughney, Trung N Tran, Heath Heatley, et al.
Plos One|September 23, 2016
Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort StudyDavid B Price, Richard Russell, Rafael Mares, et al.
Respiratory Medicine|July 23, 2017
Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluationSimon Wan Yau Ming, John Haughney, Iain Small, et al.
Thorax|December 27, 2022
Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthmaHeath Heatley, Trung N Tran, Arnaud Bourdin, et al.
The Journal of Allergy and Clinical Immunology. Global|March 25, 2024
Longitudinal patterns of intermittent oral corticosteroid therapy for asthma in the United KingdomTrung N Tran, Heath Heatley, Jennifer Rowell, et al.
Pageof 3